All years practical
First stage | ||||
No. | lecture title | Lecture content | hours | |
1 | Human Biology | The microscope | 2 | |
The cells | 2 | |||
The tissues (Single epithelial tissue) | 2 | |||
Connective tissue | 2 | |||
Muscular tissue | 2 | |||
Nervous tissue | 2 | |||
Bone & Cartilage | 2 | |||
Digestive system(digestion) | 2 | |||
Digestive system (Small & Large intestine) | 2 | |||
Blood | 2 | |||
The Chromosome | 2 | |||
Cell division (Mitosis) | 2 | |||
Cell division (Meiosis) | 2 | |||
Excretory system | 2 | |||
Skin | ||||
2 | ||||
Analytical Chemistry | Demonstration of some laboratory equipments. | 2 | ||
Separation and identification of group 1 cations | 2 | |||
(individual test). | ||||
Analysis of group 1 cataions mixture. | ||||
4 | ||||
Preparation and standardization of an acid. | ||||
2 | ||||
Determination of the percentage of acetic acid. | ||||
2 | ||||
Analysis of sodium carbonate and sodium hydroxide mixture. | 2 | |||
Determination of chloride by the Mohr method. | ||||
2 | ||||
Determination of chloride by the Volhard | ||||
method. | 2 | |||
Preparation and standardization of 0.1N | ||||
KMnO4. | 4 | |||
Determination of ferrous form of iron in Mohr’s salt. | ||||
Determination of total hardness in tab water. | ||||
2 | ||||
Gravimetric determination of Nickel. | ||||
4 | ||||
Human Anatomy | Directional term for Anatomy | 2 | ||
Skeletal system axial skeleton | ||||
2 | ||||
Skeletal system appendicular skeleton | 2 | |||
Appendicular muscles | 2 | |||
Axial muscles | ||||
2 | ||||
Joints of the body | 2 | |||
Circulatory system: | 2 | |||
Location of vascular system (Heart, Arteries, Veins) | ||||
Digestive system: | 2 | |||
–location of different parts of digestive tract (GIT) (Oral cavity, Mouth, Esophagus & Stomach) | ||||
-Small intestine, Large intestine, Rectum & Anus. | ||||
Digestive system: | ||||
Glands associated with the digestive tract by location (Salivary glands, Pancreas, Liver & Gall bladder). | ||||
2 | ||||
Respiratory system: | 2 | |||
-Conducting portion (Nose, Nasopharynx, Trachea Bronchus & Bronchioles). | ||||
-Respiratory portion (Lung) | ||||
Urinary system: | 2 | |||
-location of the (kidney & nephrone) | ||||
Nervous system: | 2 | |||
Central & Peripheral nervous system by location | ||||
Medical Physics | Explain how to plot graph and make laboratory | |||
report. | 2 | |||
Optical Fiber Loss (bend) Measurement. | ||||
2 | ||||
Simple pendulum. | ||||
2 | ||||
Spectral photometric | ||||
2 | ||||
Density of liquid. | ||||
2 | ||||
6 | The focal length of convex lens. | |||
2 | ||||
application computer in medical physics | ||||
2 | ||||
Measurement of Viscosity of liquids. | ||||
2 | ||||
Ostwald´s Viscometer: find viscosity of | ||||
unknown; find the molecular | ||||
weight; find concentration of unknown substance. | 4 | |||
Measuring surface tension (by capillary rise | ||||
method and traveling microscope). | ||||
2 | ||||
Measuring surface tension (differential height capillary method). | ||||
2 | ||||
Decay curve and half life. | ||||
2 | ||||
Boyle’s Law. | ||||
2 | ||||
Speed of sound. | ||||
2 | ||||
Laser application for measurement of single slit. | ||||
2 | ||||
Histology | Circulatory system (Artery & Vein) | 2 | ||
Lymphatic system (Thymus gland & spleen) | 2 | |||
Lymphatic system (Lymph node & Islet of | ||||
Langerhans) | 2 | |||
Nervous system (Cerebral & cerebrum cortex) | 2 | |||
Nervous system (Spinal cord) | 2 | |||
Respiratory system (Trachea & lung) | 2 | |||
Digestive system (Tongue, Esophagus & | ||||
Stomach) | 2 | |||
Digestive system (Small & Large intestine) | 2 | |||
Digestive system Digestive system | 2 | |||
-Accessory glands of the digestive system (liver | ||||
& Pancreas) | ||||
2 | ||||
7 | Endocrine system (Pituitary & Thyroid gland) | 2 | ||
Endocrine system (Adrenal & pineal gland) | 2 | |||
Male reproductive system (Testes & prostate | ||||
gland) | 2 | |||
Female reproductive system (Ovary & Uterus) | 2 | |||
Urinary system (Kidney & Urinary bladder) | 2 | |||
Skin (Thick & Thin skin) | 2 | |||
organic chemsitry I | Determination of melting point (Known sample). | 2 | ||
Determination of melting point (quiz and unknown). | 2 | |||
Determination of boiling point (known sample). | 2 | |||
Determination of boiling point (quiz and unknown). | 2 | |||
Elemental analysis (explanation of basic concepts). | 2 | |||
Elemental analysis (known quantity and quality sample). | 2 | |||
Solution and filtration techniques (explanation of basic concepts). | 2 | |||
Re-crystallization (known sample). | 2 | |||
Re-crystallization (quiz and unknown sample). | 2 | |||
Extraction technique (known sample). | 2 | |||
Extraction technique (quiz and unknown). | 2 | |||
Distillation techniques (known samples). | 2 | |||
Distillation techniques (quiz and unknown). | 2 | |||
Sublimation technique (known sample). | 2 | |||
Sublimation technique (quiz and unknown). | 2 | |||
Practical Pharmaceutical Calculation | Demonstration of different glass wares and equipments used in the field of pharmacy. | 2 | ||
Pharmaceutical measurements. | 2 | |||
Volume measurements. | 2 | |||
Preparation of aromatic waters. | 4 | |||
Preparation of simple solutions. | 4 | |||
Reducing and enlarging prescription contents. | 6 | |||
Percentages in calculating prescription contents. | 4 | |||
Stock solutions and dilution technique during dispensing technique. | 6 | |||
Computer science 1st semester | · Home Tab | 2 | ||
· Modifying Spreadsheets | ||||
· Move/Copy Cells | ||||
· Insert Tab | 2 | |||
Ø Tables | ||||
Ø Illustration | 1 | |||
Ø Charts | 2 | |||
Ø Create a Chart | 1 | |||
Ø Move Chart to New Sheet | ||||
Ø Change Chart Name | ||||
Ø Change Chart Layout | 2 | |||
Ø Change Chart Style | ||||
Ø Chart or Axis Titles | ||||
Ø Data Labels | 2 | |||
Ø Legend | ||||
Ø Move or Resize Chart | ||||
Ø Formatting an Excel Trendline | ||||
Ø Reports | 2 | |||
Ø Sparklines | 2 | |||
Ø Filter | 2 | |||
Ø Links | ||||
Ø Symbols | ||||
· Formulas Tab | 4 | |||
Ø Function Library | ||||
Ø Defined Names | ||||
Ø Formula Auditing | ||||
Ø Calculation | 2 | |||
· Data Tab | ||||
Ø Data tab contains 5 groups:- | ||||
1- Get external data | 1 | |||
2- Connections | 1 | |||
3 – Sort & filter | 1 | |||
4- Data Tools | 1 | |||
5- Outline | 1 | |||
· Add Data Analysis | 2 | |||
Ø T-test | ||||
Computer science 2st semester | Introducing Operating System Window 7 | 2 | ||
Microsoft Office Professional 2010 | 2 | |||
Introduction Microsoft Word 2010 | 2 | |||
Microsoft Office Interface. | ||||
File Ribbon Tab | ||||
Microsoft Office Quick Access Toolbar | ||||
Appearance of Microsoft Word | ||||
Creating a New Document | ||||
Opening a Document | 2 | |||
Home Tab | 2 | |||
Insert Tab – Inserting Objects | 2 | |||
Page Layout Tab – Document Layout | 2 | |||
References Tab | 2 | |||
Review Tab | 2 | |||
Mailings Tab – Mail Merge | 2 | |||
Introduction Power Point 2010 | 2 | |||
Microsoft Office Interface. | 2 | |||
File Ribbon Tab | 2 | |||
Microsoft Office Quick Access Toolbar | 2 | |||
Appearance of Microsoft Word | 2 | |||
Creating a New Document | 2 | |||
Opening a Document | 2 | |||
Home Tab – Styling your Presentation | 2 | |||
Insert Tab – Inserting Objects | 2 | |||
Design Tab – Slide Layout | ||||
Transitions Tab | ||||
Animations Tab | 2 | |||
Slide Show Tab | 2 | |||
Review Tab | 2 | |||
All years theoretical
First stage | |||||
No. | Lecture title | Hours | |||
Biology | 2 | ||||
Cell | 2 | ||||
Tissues, bone and cartilages | 3 | ||||
Nervous system (central & peripheral) | 4 | ||||
Nutrition | 2 | ||||
Digestive system (Mouth, Esophagus, | |||||
Stomach) | 2 | ||||
Digestive system (intestine) | 1 | ||||
Excretory system & respiration | 3 | ||||
Human genetics (chromosomes & semi- lethal genes) | 3 | ||||
1 | Human Biology | Skin | 2 | ||
Circulatory system | 3 | ||||
Immunity (Inflammation, immunity & the | |||||
blood , immunity to disease) | 3 | ||||
Principles of Pharmacy Practice | Some fundamentals of measurements and | ||||
calculations. | 4 | ||||
Interpretation of prescription or medication orders. | 4 | ||||
The metric system. | 4 | ||||
Calculation of doses. | 4 | ||||
Reducing and enlarging formulas. | 4 | ||||
2 | Density, specific gravity and specific volume. | 4 | |||
Percentage and ratio strength calculation. | 6 | ||||
Review of elementary concept important to | |||||
analytical chemistry: Strong and weak electrolytes; important weight and concentration units. | 4 | ||||
The evaluation of analytical data: Definition of terms | |||||
3 | Analytical Chemistry | An introduction to gravimetric analysis: Statistical | |||
analysis of data; rejection of data; precipitation methods; gravimetric factor. | 9 | ||||
The scope of applications of gravimetric analysis: | |||||
Inorganic precipitating agents; organic precipitating agents. | 4 | ||||
An introduction to volumetric methods of analysis: Volumetric calculations; acid-base equilibria and pH calculations. | |||||
5 | |||||
Buffer solutions: Theory of neutralization titrations | |||||
of simple system. | 3 | ||||
Theory of neutralization titrations of complex | |||||
system; Precipitation titrations. | 5 | ||||
Calculation of pH in complex system; Volumetric | |||||
methods based on complex system. | 4 | ||||
Equilibria in oxidation-reduction system; theory of | |||||
oxidation-reduction titrations. | 6 | ||||
Spectrophotometric analysis: An introduction to | |||||
optical methods of analysis; Methods based on absorption of radiation. | 4 | ||||
Mathematics: General concepts; coordinate and graph in plane; | |||||
inequality; absolute value or magnitude; function and their graphs; | |||||
displacement function; slope and equation for lines. | 6 | ||||
Limits and continuity: Limits; theorem of limits; limit involving | |||||
infinity; continuity; continuity conditions. | |||||
4 | |||||
Derivatives: Line tangent and derivatives; | |||||
differentiation rules; | |||||
derivative of trigonometric function; practice exercises. | 6 | ||||
Mathematics and Biostatistics | Integration: Indefinite integrals; rules for indefinite | ||||
integrals; integration | |||||
formulas for basic trigonometric function; definite integrals; properties of definite integrals; practice exercises. | |||||
6 | |||||
Biostatistics: General concepts of statistics; | |||||
statistical methods; | |||||
statistical theory; applied statistics; statistical operations. | 2 | ||||
Probability concepts: Properties of probability; Set | |||||
theory and set | |||||
notation (basic notation); counting techniques- permutations and combinations; calculating the probability of an events; probability distribution of discrete variable; binomial distribution, Poisson distribution; continues probability distribution and normal distribution, review questions and exercises. | 6 | ||||
The concept of central tendency: Mean of sample and mean of | |||||
population; median; mode; measure of central tendency; review questions and exercises. | 6 | ||||
Deviations and variation: Deviation; dispersion and | |||||
variability; standard | |||||
deviation and variance; coefficient of variations; standard error; correlation analysis.(regression model and sample regression equation); application of statistic in medical field; review questions and exercises. | 9 | ||||
Medical Terminology | Basic word roots and common suffixes | 1 | |||
More word roots, suffixes and prefixes related to pharmaceutical sciences (pharmacognosy, clinical pharmacy, pharmaceutics,…etc) | |||||
1 | |||||
Basic anatomical terms and abnormal conditions | 2 | ||||
The genitals and urinary tract | 1 | ||||
The gastrointestinal tract | 1 | ||||
The heart and cardiovascular system | |||||
1 | |||||
Symptoms, diagnoses, treatments, communication | |||||
qualifiers, and statistics | 2 | ||||
Growth and development, and body orientation | 1 | ||||
6 | Gynecology, pregnancy, and childbirth | 1 | |||
The eye and the respiratory tract | 1 | ||||
The nervous system and behavioral disorders | 2 | ||||
Blood and immunity | 1 | ||||
Circulatory system: | |||||
Location of vascular system (Heart, Arteries, Veins) | 1 | ||||
Circulatory system: | |||||
Location of lymphatic system (Lymphatic capillary). | 1 | ||||
Lymphoid tissue: | |||||
location of the (Thymus gland, Spleen & Lymph nodes) | 1 | ||||
Lymphoid nodule (MALT) & Tonsils | 1 | ||||
Nervous system: | |||||
7 | Human Anatomy | Central & Peripheral nervous system by location | 1 | ||
Respiratory system: | |||||
-Conducting portion (Nose, Nasopharynx, Trachea Bronchus & Bronchioles). | |||||
-Respiratory portion (Lung) | 1 | ||||
Digestive system: | |||||
–location of different parts of digestive tract (GIT) (Oral cavity, Mouth, Esophagus & Stomach) | |||||
-Small intestine, Large intestine, Rectum & Anus. | |||||
2 | |||||
Digestive system: | |||||
Glands associated with the digestive tract by location (Salivary glands, Pancreas, Liver & Gall bladder). | |||||
1 | |||||
Endocrine system: | |||||
-location of the pituitary gland | |||||
–location of the Adrenal, Thyroid, Parathyroid, Islet of Langerhans & Pineal glands. | 1 | ||||
Male reproductive system: | |||||
–location of the testes. | 2 | ||||
-Excretory genital ducts | |||||
-Excretory genital glands (Seminal vesicles, Prostate & Cowper’s glands) | |||||
Female reproductive system: | |||||
-location of ovary, Oviduct, Uterus & Vagina. | 2 | ||||
Urinary system: | |||||
-location of the (kidney & nephrone) | 1 | ||||
– location of the (Ureter, Bladder & Urethra). | |||||
Dilution and concentration of pharmaceutical | |||||
preparations. | 10 | ||||
Pharmaceutical Calculations by Stoklosa | Isotonic solutions. | 6 | |||
Electrolyte solutions (milliequivalents, millimoles and milliosmoles). | |||||
8 | 6 | ||||
Constituted solutions, I.V admixtures and flow rate | |||||
calculations. | 8 | ||||
General concepts: Method of physics and | |||||
standards; thermodynamics | |||||
system and system properties; conservation of energy principle; | |||||
application of thermodynamics; the Zeroth law. | 3 | ||||
Pressure; temperature and temperature scales | |||||
(Celsius, Fahrenheit, | |||||
9 | Medical Physics | Kelvin); equation of state; ideal gas and real gas; general law of gases; clauses equation and Vander Waales equation; equilibrium and types of equilibrium; compressibility factor, coefficient of volume expansion, elastic coefficient (bulk modulus). | 6 | ||
Heat and energy; work and mechanical forms of | |||||
work; power; the 1st | |||||
law of thermodynamics; Boyles and Charles law; practice exercises. | 3 | ||||
The 2nd law of thermodynamics; reversible and | |||||
irreversible process; | |||||
entropy and enthalpy; internal energy; heat capacity and adiabatic process; the relation between pressure, volume, and temperature in adiabatic process. | |||||
6 | |||||
Fundamental of physics: Kinetic theory of a gas; electromagnetic waves; | |||||
Maxwell equations; physical optics. | 6 | ||||
Radiation: Kirshoffs law; planks law; Stefan- | |||||
Boltzman law; Wiens law; | |||||
Black body and Albedo; Heat transfer (radiation, convection, conduction). | 6 | ||||
Production of X-Ray and X-Ray spectra; absorption | |||||
of X-Ray; U.V and | |||||
IR effects; medical and biological effects of radiation; radiotherapy. | 3 | ||||
Introduction. | 3 | ||||
Alkanes and methane. | 6 | ||||
Alkenes I and II | 5 | ||||
Alkynes and dienes. | 5 | ||||
Stereochemistry I & II | 8 | ||||
Alcohols and ethers. | 8 | ||||
10 | Organic Chemistry I | Alkyl halides. | 6 | ||
Cycloalkanes. | 4 | ||||
Circulatory system: | |||||
Structure of the vascular system (Heart wall, Arteries, Veins & Capillaries) | 2 | ||||
Circulatory system: | |||||
Structure of the lymphatic system (Lymphatic capillary). | 1 | ||||
Lymphoid tissue: | |||||
Structure & function of the (Thymus gland, Spleen | 1 | ||||
& Lymph nodes) | |||||
Lymphoid nodule (MALT) & Tonsils | 1 | ||||
11 | Histology | Nervous system: | |||
Central & Peripheral nervous system | 3 | ||||
Respiratory system: | |||||
-Conducting portion (Nose, Nasopharynx, Trachea Bronchus & Bronchioles). | |||||
-Respiratory portion (Lung) | 3 | ||||
Digestive system: | |||||
–Digestive steps. | |||||
–General structure of the digestive tract (GIT) (Oral cavity, Mouth, Esophagus & Stomach) | |||||
-Small intestine, Large intestine, Rectum & Anus. | 3 | ||||
Digestive system: | |||||
Glands associated with the digestive tract (Salivary glands, Pancreas, Liver & Gall bladder0. | 1 | ||||
Endocrine system: | |||||
-General structure of the pituitary gland | 2 | ||||
-Histophysiologies of the pituitary gland. | |||||
Endocrine system: | |||||
-General structure of the Adrenal, Thyroid, | |||||
Parathyroid, Islet of Langerhans & Pineal glands. | 2 | ||||
Male reproductive system: | |||||
–General structure of the testes. | |||||
-Stages of spermatogenesis. | 2 | ||||
Male reproductive system: | |||||
-Excretory genital ducts-Excretory genital glands | 1 | ||||
(Seminal vesicles, Prostate & Cowper’sglands) | |||||
Female reproductive system: | |||||
-General structure of ovary, Oviduct, Uterus & Vagina. | |||||
-Stages of follicle development. | |||||
-Ovulation | 3 | ||||
Urinary system: | |||||
-Structure & Function of the (kidney & nephrone) | |||||
-Histology of the nephrone (filtration, absorption & excretion). | |||||
– Structure of the (Ureter, Bladder & Urethra). | 3 | ||||
The skin | |||||
Thick & Thin skin | 2 | ||||
Hello | 2 | ||||
Your world | 2 | ||||
All about you | 2 | ||||
English (John and Liz Soars, New Headway Plus, Oxford: Oxford | Family and friends | 2 | |||
The way I live | 2 | ||||
Every day | 2 | ||||
My favorites | 3 | ||||
Where I live | 2 | ||||
Times past | 2 | ||||
We had a great time | 2 | ||||
I can do that | 2 | ||||
Please and thank you | 2 | ||||
Here and now | 3 | ||||
Its time to | 2 | ||||
Second stage | |||||
Lecture title | |||||
hours | |||||
Aromatic Hydrocarbons (includes benzene, electrophilic aromatic substitution, arenas and their derivatives). | 10 | ||||
Carboxylic acids: properties and reactions. | 5 | ||||
Functional derivatives of carboxylic acids. | |||||
7 | |||||
Amines I and II. | 6 | ||||
1 | Organic Chemistry II | Aldehydes and ketones (include also aldol and Claisen | |||
condensation); Classification, reactions and properties. | 12 | ||||
Phenols. | 5 | ||||
Introduction: Importance of microbiology, History of microbiology | 2 | ||||
Anatomy of bacteria: Surface appendages, Capsule, Cell wall of | |||||
G.+ve & G –ve bacteria, Cytoplasmic membrane. | |||||
2 | |||||
Bacterial physiology: Physical and chemical growth determinate, growth and growth curves, bacterial reproduction. | 3 | ||||
Genetics: Definition, genetic, element, mutation (spontaneous, | 2 | ||||
Gene transfer, transformation, conjugation, and gene transduction). | |||||
Recombinant DNA biotechnology. | |||||
Medical Microbiology, | 1 | ||||
Sporulation and germination. | |||||
1 | |||||
Sterilization (chemical + physical Methods). | |||||
2 | |||||
Chemotherapy and sensitivity test | |||||
3 | |||||
Staphylococci species | |||||
3 | |||||
Streptococcus species | |||||
3 | |||||
Aerobic Spore-forming bacteria Bacillus species (B. anthracis, B. | |||||
subtilis, B. cereus). | |||||
2 | |||||
Clostridium perfringens; Clostridium tetani; Clostridium botulinun | |||||
3 | |||||
Corynebacterium diphtheriae | |||||
2 | |||||
Propionibacterium acnes, Listeria | |||||
2 | |||||
Mycobacterium tuberculosis; M. leprae | |||||
2 | |||||
Enterobacteriaceae: (E. coli; Klebsiella spp.; Citrobacter , Serratia, Salmonella, Shigella) | |||||
6 | |||||
, Vibrio, Pseudomonas, Helicobacter pylori, Neisseria spp., Brucella, Proteus, | |||||
6 | |||||
The general and cellular basis of medical physiology. | 5 | ||||
Physiology of nerves and muscles: Nerve cells; excitation | 16 | ||||
: Physiology I | and conduction; Properties | ||||
of mixed nerves; glia; neurotrophins; Nerve fiber types and functions; Muscles: Skeletal muscle; smooth muscle; cardiac muscle. Synaptic transmission: Reflexes; cutaneous, deep and visceral sensations; alert behavior, sleep and electrical activity of the brain; control of posture and movement; higher function of the nervous system; central regulation of visceral function; the autonomic nervous system. | |||||
Respiration: Respiratory zones; Mechanics of respiration; air | 8 | ||||
volumes; respiratory | |||||
muscles; compliance of the lungs and chest wall; surfactants; differences in ventilation and blood flow in deferent parts of the lung; Dead space and uneven ventilation; Pulmonary circulation: Pressure, volume and flow. Gas transport between the lungs and tissue; Regulation of respiration: Neural control of breathing; | |||||
Respiratory centers; Regulation of respiratory activity: Chemical factors; non chemical factors; Respiratory adjustment in health and disease; Effect of exercise; Hypoxia; Emphysema; Asthma. | |||||
Renal Physiology: Introduction; innervations of the renal | 8 | ||||
vessels; renal clearance; | |||||
renal blood flow; glomerular filtration rate (GFR): Measurements; factor affecting GFR; Filtration fraction; reabsorption of Na+, Cl – and glucose. Tubuloglomerular feedback and glomerulotubular balance; water excretion in: proximal tubules; loop of henle; distal tubules; collecting ducts; the counter current mechanism; role of urea; water diuresis and osmotic diuresis; acidification of the urine: H+ secretion; reaction with buffers; ammonia secretion; factors affecting acid secretion; bicarbonate execration; regulation of Na+, K+ and Cl – excretion; uremia; acidosis; micturition. | |||||
Cardiovascular system: origin and spread of cardiac | 8 | ||||
excitation; the electrocardiogram; | |||||
cardiac arrhythmias; electrographic findings in cardiac diseases; mechanical events of the cardiac cycle; cardiac output; cardiovascular regulatory mechanisms: Local regulatory mechanisms; systemic regulation by the nervous system; systemic regulation by hormones; Coronary circulation; Hypertension; Heart failure; Angina pectoris. | |||||
States of matter, binding forces between molecules, gases, | 10 | ||||
liquids, solid and crystalline matters; phase equilibria and phase rule; thermal analysis. | |||||
Thermodynamics, first law, thermochemistry, second law, | 8 | ||||
third law, free energy function and applications. | |||||
Solutions of non-electrolytes, properties, ideal and real | 7 | ||||
Colligative properties, molecular weight determination. | |||||
Physical Pharmacy I | Solution of electrolytes, properties, Arrhenius theory of | 5 | |||
dissociation, theory of strong electrolytes, ionic strength, Debye-Huchle theory, coefficients for expressing colligative properties. | |||||
Ionic equilibria, modern theories of acids, bases and salts, | 8 | ||||
acid-base equilibria, calculation of pH, acidity constants, the effect of ionic strength and free energy. | |||||
Buffered and isotonic solutions: Buffer equation; buffer | 7 | ||||
capacity; methods of adjusting tonicity and pH; buffer and biological system. | |||||
Heterocyclic system: Classes of heterocyclic systems; | |||||
general structures; properties; Occurrence in nature and in medicinal products. | 5 | ||||
Five-membered ring heterocyclic compounds: pyrrole; furan | |||||
and thiophen. | 3 | ||||
Source of pyrrole, furan and thiophen. | 2 | ||||
Electrophilic substitution in pyrrole, furan and thiophen: | |||||
Reactivity and orientation. | 5 | ||||
Organic ChemistryIII | Six-membered ring heterocyclic compounds: Structure & | ||||
reactions of pyridine. | 4 | ||||
Saturated five-membered heterocyclic compounds. | 6 | ||||
Heterocyclic of five & six member rings with two & three | |||||
heteroatoms. | 5 | ||||
Introduction. | 1 | ||||
Intestinal and tissue protozoa (Amoeba (pathogenic and non pathogenic), Balantidium, Giardia, Trichomonas | 4 | ||||
Chilomastix) | |||||
Medical Virology, immunology, and Parasitology | Haemoflagellates: Leishmania spp.; Trypanosome spp. | 4 | |||
Sporozoa: Malarial parasites of human; Toxoplasma. | 3 | ||||
Helminthes: Classification, Cestodes (Hymenolepis nana, Taenia spp.), Echinococcus (Hydatid cyst). | 8 | ||||
Hepatic flukes, Trematodes (Blood Flukes: Schistosoma spp). | |||||
Nematods: Ascaris, Entrobius. Trichuris, Ancylostoma, Necator americans. | |||||
Virology: Introduction, Comparison between viruses and | 10 | ||||
Bacteria and other microbes; origin of viruses, reproduction, one step growth curve, type of mutations and Classification of viruses; RNA viruses: Orthomyxo viruses; Paramyxo viruses; Retro viruses; Hepato viruses; Oncogenic viruses. DNA viruses: Herpes viridae; poxviradeae, adenoviredeae, parvoviruses | |||||
Immunology: introduction, innate and adaptive immunity, complement, MHC molecule and autoimmune diseases, hypersensitivity, tumor immunity, immunodeficiency, immunological methods. | 15 | ||||
Solubility and distribution phenomena, solvent-solute | 10 | ||||
interactions, | |||||
solubility of gases in liquids, solubility of liquids in liquids, solubility of non-ionic solids in liquids, distribution of solutes between immiscible solvents. | |||||
Complexation, classification of complexes, methods of | 5 | ||||
analysis, | |||||
thermodynamic treatment of stability constants. | |||||
Kinetics, rate and orders of reactions, influence of | 9 | ||||
temperature and other | |||||
factors on reactions rate, decomposition of medicinal agents and accelerated stability analysis. | |||||
Physical PharmacyII by Alfred Martin et a | Interfacial phenomena, liquid interfaces, surface free energy, | 5 | |||
measurement of interfacial tension, spreading coefficient, surface active agents and wetting phenomena. | |||||
Colloids, dispersed system and its pharmaceutical | 5 | ||||
application, types of | |||||
colloidal systems, kinetic properties, diffusion, zeta potential, solubilization. | |||||
Micrometrics, particle size, methods of determining particle | 3 | ||||
size, particle shape and surface area, porosity, density. | |||||
Rheology, Newtonian systems, thixotropy measurement, | 5 | ||||
Negative thixotropy, determination of thixotropy. | |||||
Polymer science, definitions pharmaceutical applications, | 3 | ||||
molecular eight averages. | |||||
Gastrointestinal function: Digestion and absorption of | 10 | ||||
carbohydrates; proteins; lipids; absorption of water and electrolytes; vitamins and minerals; regulation of gastrointestinal function: Introduction; gastrointestinal hormones; mouth and esophagus; stomach; exocrine portion of the pancreas; liver and biliary system; small intestine; colon. | |||||
Circulatory body fluid: Introduction; blood; bone marrow; | 15 | ||||
Physiology II | white blood cells; immunity; platelets; red blood cells; anemia; polycythemia; blood group and Rh factor; hemostasis: The clotting mechanism / blood coagulation tests; anti clotting mechanism; the plasma; the lymph; abnormalities of hemostasis. | ||||
Endocrinology: Introduction; energy balance, metabolism | 20 | ||||
and nutrition; the pituitary gland; the thyroid gland; the gonads: development and function of the reproductive system; the adrenal medulla and adrenal cortex; hormonal control of calcium metabolism and the physiology of the bone; endocrine functions of the pancreas and regulation of carbohydrate metabolism. | |||||
Getting to know you. | 2 | ||||
The way we live | 2 | ||||
It all went wrong | 2 | ||||
Let’s go shopping | 2 | ||||
What do you want to do? | 2 | ||||
Tell me! What’s it like? | 2 | ||||
English | Famous couples | 2 | |||
Do’s and Don’ts | 2 | ||||
Liz and John Soar, New Headway Plus – Pre-Intermediate. Oxford: Oxford University Press | Going places | 2 | |||
Scared to death | 2 | ||||
Things that changed the word | 3 | ||||
Dreams and reality | 3 | ||||
Earning living | 2 | ||||
Love you and leave you | 2 | ||||
General Introduction: The Scope of Pharmacognosy, | 3 | ||||
definitions and basic principles. | |||||
Drugs from natural sources, crud drugs, official and non- | 1 | ||||
official drugs. | |||||
Classification of natural products. | 2 | ||||
Plant nomenclature and taxonomy. | 2 | ||||
Production of crude drugs: Cultivation, collection, drying | 3 | ||||
and storage. | |||||
Deterioration of crude natural products. | 1 | ||||
Chemistry of natural drug products. | 3 | ||||
Quality control: Evaluation of natural products; | 4 | ||||
Pharmacognosy I | macroscopical evaluation; physical evaluation; chemical evaluation; biological evaluation; spectroscopical evaluation. | ||||
Phytochemical investigation of herbal products: Extraction | 4 | ||||
of the plant material; Separation and isolation of constituents; characterization of the isolated compounds. | |||||
Separation technique: Introduction; Mechanisms of | 15 | ||||
separation and classification based on the type of technique; paper chromatography; Thin layer chromatography; Ion- exchange chromatography; Gel filtration chromatography; Column chromatography; Gas chromatography; HPLC; Electrophoresis; Affinity chromatography. | |||||
Traditional plant medicines as a source of new drugs. | 3 | ||||
Bioassay-guided fractionation | |||||
Third stage | |||||
ةداملا | Lecture title | ||||
hours | |||||
Atomic and molecular structure/ Complexation. | 6 | ||||
Essential and trace ions: Iron, copper, sulfur, iodine. | 3 | ||||
Non essential ions: Fluoride, bromide, lithium, gold, silver and | |||||
mercury. | 2 | ||||
Gastrointestinal agents: Acidifying agents. | 1 | ||||
Antacids. | 2 | ||||
Protective adsorbents. | 1 | ||||
Topical agents. | 2 | ||||
Inorganic Pharmaceutical Chemistry | Dental agents. | ||||
1 | |||||
Radiopharmaceutical preparations. | 6 | ||||
Radio opaque and contrast media. | 6 | ||||
Introduction: General biosynthesis pathways of secondary | |||||
metabolites. | 2 | ||||
Carbohydrates. | |||||
2 | |||||
Glycosides: Biosynthesis, physical and chemical properties; cardiac | |||||
Pharmacognosy II | glycosides; saponin glycosides; anthraquinone glycosides; flavonoid glycosides; cyanophore lycosides. | 5 | |||
Glycosides: Isothiocyanate glycosides; aldehyde glycosides; alcoholic | |||||
glycosides; phenolic glycosides; lactone glycosides; coumarins and chromones. | 5 | ||||
Resins and resin combination; tannins. | |||||
2 | |||||
Lipids: fixed oils and waxes. | |||||
3 | |||||
Volatile oils: Introduction; chemistry of volatile oils; biosynthesis of | |||||
volatile oils; hydrocarbons as volatile oils; alcohols as volatile oils; aldehydes as volatile oils. | 4 | ||||
Ketones as volatile oils; Phenols as volatile oils; Oxides as volatile | |||||
oils; Ester as volatile oils; Phenolic ethers as volatile oils. | 3 | ||||
Non- medicinal toxic plants. | 2 | ||||
Vitamins and Amino acids. | |||||
2 | |||||
Dispersed systems: their classification; comparisons between | 2 | ||||
different systems. | |||||
Solutions and types of solutions. | 2 | ||||
Solubility: Factors affecting solubility; expression of dissolution; | 4 | ||||
dissolution rate versus solubility; preparation of solutions containing non-volatile materials. | |||||
Official solutions; classification of official solutions; preparation and | 4 | ||||
uses. | |||||
Aqueous solutions containing aromatic principles; aromatic waters; | 4 | ||||
methods of preparations; stability. | |||||
Syrups: sugar based syrups; artificial and sorbitol based syrups; | 4 | ||||
stability of syrups. | |||||
Definition and methods of clarification; filter aids in clarification. | 3 | ||||
Pharmaceutical Technology I | Preparation of solutions using mixed solvent systems; spirits, and | 3 | |||
elixirs. | |||||
Extraction; maceration and percolation. | 3 | ||||
Tinctures; fluid extracts; extracts of resins and oleoresins. | 4 | ||||
Colloidal dispersions; lyophilic; lyophobic. | 6 | ||||
Coarse dispersion; suspensions. | 6 | ||||
Introduction to the macromolecules biochemistry: Definitions and | 2 | ||||
terms; proteins, enzymes, DNA; Clinical value. | |||||
Amino acids: Structures of A.A (table of standard A.A abbreviation | 3 | ||||
Biochemistry I | and | ||||
side chain); Classification, properties, isomerism. | |||||
Amino acids: Chemical reactions, Zwitter ions, titration curve | |||||
calculating isoelectric point values. Examples and questions. Non standards A.A: Structures, existence and clinical value. | 3 | ||||
Peptides: Peptide bond, resonance forms, isomers, physical properties | |||||
and chemical reactions. Essential poly peptides in human body, structures, roles and clinical values. | 3 | ||||
Proteins: Structure and conformations of proteins, Primary structure, | |||||
Secondary structure (4 helix, 5 sheet), tertiary structure, quaternary structure. Classification, synthesis, cellular functions (Enzymes, cell signaling, and ligand transport, structural proteins), protein in nutrition. | 3 | ||||
Denaturation of proteins and protein sequencing: Determining A.A | 3 | ||||
composition, N- terminal A.A analysis, C- terminal A.A analysis, Edman degradation, prediction protein sequence from DNA/ RNA sequences. Methods of protein study: Protein purification, cellular localization, proteomics and bioinformatics, structure predication and simulation. | |||||
Carbohydrates: Chemistry and classification, biomedical importance, | 3 | ||||
classification of CHO, Stereochemistry of monosaccharides, metabolism of CHO; Physiologically important monosaccharides, glycosides, disaccharides, polysaccharides. | |||||
Lipids: Introduction, classification of lipids, fatty acids (F.A), | 3 | ||||
nomenclature of F.A, saturated F.A, unsaturated F.A, physical and physiological properties of F.A, metabolism of lipids. Phospholipids, lipid peroxidation and antioxidants, separation and identification of lipids, amphipathic lipids. | |||||
Enzymes: Structures and mechanism, nomenclature, classification, | 3 | ||||
mechanisms of catalysis, thermodynamics, specificity, lock and key model, induced fit model, transition state stabilization, dynamics and function, allosteric modulation. Biological function, cofactors, coenzymes, involvement in disease. | |||||
Kinetics: General principles, factors effecting enzyme rates (substrate | 2 | ||||
conc., pH, temperature, etc), single-substrate reaction (Michaelis- Menten kinetics), kinetic constants. Examples of kinetic questions and solutions. | |||||
Enzyme inhibition: Reversible inhibitors, competitive and non | 1 | ||||
competitive inhibition, mixed-type inhibition, Irreversible inhibition. Inhibition kinetics and binding affinities (ki), questions and solutions. | |||||
Control of activity and uses of inactivators; multi-substrate reactions, | 1 | ||||
ternary-complex mechanisms, ping-pong mechanisms, non- Michaelis- Menten kinetics, pre-steady-state kinetics, chemical mechanisms. | |||||
Nucleic Acid: Chemical structure, nucleic acid components, nucleic | 3 | ||||
acid bases, nucleotides and deoxynucleotides (Properties, base pairing, sense and antisense, super-coiling, alternative structures, quadruple structures. | |||||
Biological functions of DNA: Genes and genomes, transcription and | 2 | ||||
translation, replication. | |||||
Biochemistry of extracellular and intracellular communication: | 3 | ||||
Plasma | |||||
membrane structure and function; Biomedical importance, membrane proteins associated with lipid bilayer, membranes protein composition, dynamic structures of membranes, a symmetric structures of membranes. | |||||
Artificial membranes model, the fluid mosaic model, membrane | 1 | ||||
selectivity, physiological functions of plasma membranes. | |||||
Biochemistry of the endocrine system: Classification of hormones, | 3 | ||||
biomedical importance, the target cell concept and hormone receptors, biochemistry of hormone action and signal transduction. | |||||
Special topics: Nutrition, digestion, and absorption. Biomedical | 3 | ||||
importance, digestion and absorption of carbohydrates, lipids, proteins, vitamins and minerals; energy balance. Biochemistry of hemostasis and clot formation. | |||||
Introduction. | 1 | ||||
Cell injury and tissue response; Degeneration; Necrosis; Atrophy; | 6 | ||||
Hypertrophy; Metaplasia and Calcification; Inflammation and Repair. | |||||
Disorders of electrolytes and water and acid–base balances: Hyper | 4 | ||||
and | |||||
Pathophysiology | Hyponatremia; Hyper and Hypokalemia; Syndrome of inappropriate secretion of ADH; Diabetes insipidus; Metabolic acidosis and alkalosis; Respiratory acidosis and alkalosis. | ||||
Disorders of cardiovascular system: Hyperemia; Congestion and | 5 | ||||
edema; | |||||
Thrombosis; embolism and infarction; Shock; Coronary heart disease and MI; Rheumatic heart disease; Heart failure; Acute pulmonary edema; Essential hypertension; Secondary hypertension; Malignant hypertension; Hypotension; Aneurysm versus varicose veins; | |||||
Disorders of respiratory system: Pneumonias; Tuberculosis; | 3 | ||||
Respiratory | |||||
distress syndrome; Bronchial asthma; Emphysema and bronchiectasis; Cystic fibrosis; Pulmonary embolism; Pulmonary hypertension. | |||||
Disorders of the renal system: Nephrotic syndrome; | 4 | ||||
Glomerulonephritis; | |||||
Diabetic glomerulosclerosis; Hypertensive glomerular disease; Pyelonephritis; Drug related nephropathies; Acute renal failure; Chronic renal failure. | |||||
Disorders of GI and hepatobiliary systems: Peptic ulcer and Zollinger | 4 | ||||
–Ellison syndrome; Irritable bowel syndrome; Crohn’s disease; Diarrhea; Celiac disease; Viral hepatitis; Primary biliary cirrhosis; Liver failure; Cholelithiasis. | |||||
Disorders of thyroid function: Hypothyroidism. Hyperthyroidism. | 2 | ||||
Graves’s disease. Thyrotoxicosis. | |||||
Disorders of adrenal function: Cushing syndrome. Adrenal cortical | 2 | ||||
Insufficiency (primary and secondary). Congenital adrenal hyperplasia. Pheochromocytoma. | |||||
Diabetes mellitus and metabolic syndrome; | 3 | ||||
Dyslipoproteinemia. | 2 | ||||
Neoplasia | 4 | ||||
Metabolic &rheumatic disorders of skeletal system: | 2 | ||||
-Osteoporosis, osteomalacia & rickets, rheumatoidarthritis, systemic lupus erythromatosus, ankylosing spondylitis, gout, osteoarthritis syndrome. | |||||
Alterations in the immune response (pathophysiology of immunopathology): | |||||
– Hypersensitivity disorders. | |||||
– Transpalantation immunopathology. | 3 | ||||
– Immunodeficiency disorders. | |||||
Drug distribution. | 4 | ||||
Acid- base properties. | 3 | ||||
Statistical prediction of pharmacological activity. | 3 | ||||
QSAR models. | 2 | ||||
Molecular modeling (Computer aided drug design). | 1 | ||||
Drug receptor interaction: force involved. | 1 | ||||
Steric features of drugs. | 2 | ||||
Optical isomerism and biological activity. | 1 | ||||
Calculated conformation. | 1 | ||||
Three- dimensional quantitative structure activity relationships and | 1 | ||||
databases. | |||||
Isosterism. | 1 | ||||
Drug-receptor interaction and subsequent events. | 1 | ||||
Organic Pharmaceutical Chemistry I | General pathways of drug metabolism: Sites of drug | 22 | |||
biotransformation; Role of cytochrome P450 mono-oxygenases in oxidative biotransformation; Oxidative reactions; Reductive reactions; Hydrolytic reactions; Phase II reactions. | |||||
Factors affecting drug metabolism. | 2 | ||||
General introduction to Pharmacology. | 2 | ||||
Pharmacokinetics. | 4 | ||||
pharmacology I | Drug Receptor interaction and Pharmacodynamics. | 4 | |||
The autonomic nervous system (ANS). | 2 | ||||
Cholinergic system. | 6 | ||||
Adrenergic system. | 6 | ||||
Principal of antimicrobial therapy. | 2 | ||||
β- lactam and other cell wall synthesis inhibitor antibiotics | 4 | ||||
Protien synthesis inhibitors | 4 | ||||
Quinolones, Folate antagonists, and urinary tract antiseptics. | 3 | ||||
Antimycobacterium drugs | 2 | ||||
Antifungal drugs. | 2 | ||||
Antiprotozoal drugs. | 1 | ||||
Anthelmintic drugs. | 2 | ||||
Antiviral drugs. | 1 | ||||
Emulsions; purpose of emulsification; methods of emulsification; | 10 | ||||
emulsifying agents; HLB system; stability of emulsions. | |||||
Lotions; liniments and collodions. | 5 | ||||
Suppositories. | 6 | ||||
Powdered dosage forms. | 10 | ||||
Semisolid dosage forms. | 10 | ||||
Pharmaceutical Technology II | Incompatibilities in pharmaceutical dosage forms. | 4 | |||
Bioenergetics. | 2 | ||||
Biologic oxidation. | 2 | ||||
The respiratory chain and oxidative phosphorylation. | 2 | ||||
Over view of metabolism. | 2 | ||||
Citric acid Cycle. | 2 | ||||
Glycolysis. | 2 | ||||
Metabolism of glycogen. | 4 | ||||
Gluconeogenesis. | 3 | ||||
Pentose phosphate pathway and other pathways of hexose | 3 | ||||
Biochemistry II | metabolism. | ||||
Biosynthesis of fatty acids. | 3 | ||||
Oxidation of fatty acids. | 2 | ||||
Metabolism of acylglycerol and sphingolipids. | 2 | ||||
Lipid transport and storage. | 2 | ||||
Cholesterol synthesis, transport, and excretion. | 2 | ||||
Biosynthesis of the Nutritionally Nonessential Amino Acids. | 3 | ||||
Catabolism of Proteins & of Amino Acid Nitrogen | 3 | ||||
Catabolism of the Carbon Skeletons of Amino Acids. | 2 | ||||
Conversion of Amino Acids to Specialized Products. | 2 | ||||
Porphyrins & Bile Pigments | 2 | ||||
Alkaloids: Introduction; Physical and chemical properties; pyridine, | 5 | ||||
piperidine alkaloids; tropane alkaloids. | |||||
Alkaloids: Quinoline tropan alkaloids; iso-quinoline alkaloids; | 5 | ||||
imidazole alkaloids; indole alkaloids. | |||||
Alkaloids: Steroidal alkaloids; lupinane alkaloids; alkaloidal amines; | 4 | ||||
Pharmacognosy III | purine alkaloids. | ||||
Antibiotics: Natural sources; biosynthetic pathways, isolation and | 6 | ||||
purification. | |||||
.phytotherapy :Introduction , principles,medicinal plants in selected | 10 | ||||
health care systems.Important natural products & phytomecines used in pharmacy & medicine | |||||
Introduction to Pharmacy Ethics (Theoretical considerations). | 2 | ||||
Code of Ethics for Pharmacists. | 1 | ||||
Common Ethical Considerations in Pharmaceutical Care Practice | |||||
(Beneficence, Autonomy, Honesty, Informed Consent, Confidentiality, Fidelity ………). | 3 | ||||
Interprofessional Relations. | 2 | ||||
Making ethical decisions. | 1 | ||||
Ethical issues related to clinical pharmacy research. | 1 | ||||
Ethical problems in the pharmacist’s clinical practice. | 1 | ||||
Preventing misuse of medicines. | 1 | ||||
Case studies in pharmacy ethics. | 3 | ||||
Fourth stage | |||||
Lecture title | hours | ||||
Pharmacology II | Introduction to CNS pharmacology. | 2 | |||
CNS stimulants. | 2 | ||||
Anxiolytic and Hypnotic drugs. | 3 | ||||
General and Local Anesthetics. | 3 | ||||
Antidepressant drugs. | 3 | ||||
Antipsychotic (neuroleptic) drugs. | 3 | ||||
Opioid analgesics and antagonists. | 3 | ||||
Treatment of neurodegenerative diseases. | 3 | ||||
Antiepileptic Drugs. | 2 | ||||
Diuretics. | 2 | ||||
The treatment of heart failure (HF). | 2 | ||||
Antiarrhythmic drugs. | 2 | ||||
Antianginal Drugs. | 2 | ||||
Antihypertensive drugs. | 3 | ||||
Drugs affecting the blood. | 3 | ||||
Antihyperlipidemic drugs. | 2 | ||||
Gastrointestinal and antiemetic drugs. | 2 | ||||
Drugs acting on the respiratory system. | 3 | ||||
Cholinergic agents, cholinergic receptors and their subtypes. | 3 | ||||
Cholinergic agonists; stereochemistry and structure-activity | 5 | ||||
relationships (SAR); products; cholinesterase inhibitors. | |||||
organic pharmaceutical chemistry | Cholinergic blocking agent; structure-activity relationships (SAR); | 5 | |||
Solanaceous alkaloid and analogues; synthetic cholinergic blocking agents and products; ganglionic blocking agents (neuromuscular blocking agents). | |||||
Analgesic agents (SAR of morphine, SAR of meperidine type | 5 | ||||
molecules; SAR of methadone type compounds; N- methylbezomorphans, antagonist type analgesics in benzomorphans). | |||||
Analgesic receptors, endogenous opioids; Products; Antitusive | 5 | ||||
agents; Anti-inflammatory analgesics. | |||||
Adrenergic agents (Adrenergic neurotransmitters); Adrenergic | 8 | ||||
receptors; Drugs affecting Adrenergic neurotransmission; Sympathomimetic agents; Adrenergic receptor antagonists. | |||||
CNS depressant; Benzodiazepines and related compounds; | 7 | ||||
Barbiturates; CNS depressant with skeletal muscle relaxant properties; Antipsycotics; Anticonvulsants. | |||||
CNS Stimulants | 3 | ||||
Steroidal & nonsteroidal hormones | 4 | ||||
Introduction to community pharmacy. | 1 | ||||
Respiratory problems: Cough, Common cold, allergic rhinitis, Otitis media, Laryngitis & Pharyngitis | |||||
3 | |||||
G.I.T problemse: Diarrhea, Constipation, Heart burn and indigestion, IBS and Hemorrhoids | |||||
4 | |||||
Pediatric care practice : Oral thrush, pinworms and head lice | 2 | ||||
Skin conditions: Acne, Scabies, Psoriasis, Hair loss, Fungal | |||||
infection, Eczema and Dermatitis , Dandruff, Cold sore, Corns and Callus. | 5 | ||||
Women’s health care: Cystitis and vaginal thrush, primary | |||||
dysmenorrhea and Premenstrual syndrome. | |||||
2 | |||||
CNS related problems: Headache, Insomnia, Motion sickness, Nausea and vomiting | 3 | ||||
– Eye problems | 1 | ||||
ENT problems | 1 | ||||
Clinical Pharmacy1 | Oral hygiene, mouth ulcer | 1 | |||
Obesity and body weight control. | 1 | ||||
– Pain and musculoskeletal disorders | 1 | ||||
Nicotine replacement therapy ( NRT). | 1 | ||||
Dietary supplements | 1 | ||||
An update in reclassification of OTC drugs ( simvastatin, Tamusotisin & azithromycin). | |||||
2 | |||||
Medication adherence and errors. | 1 | ||||
Introduction to biopharmaceutics. | 2 | ||||
Biopharmaceutics | Biopharmaceutic aspects of products; drug absorption; | 6 | |||
mechanisms of | |||||
absorption; physicochemical factors; dissolution rate; effects of excipients; type of dosage forms. | |||||
One compartment open model. | 2 | ||||
Multicompartment models. | 2 | ||||
Pharmacokinetics of drug absorption. | 2 | ||||
Bioavailability and bioequivalence. | 2 | ||||
Clearance of drugs from the biological systems. | 2 | ||||
Hepatic elimination of drugs. | 2 | ||||
Protein binding of drugs. | 2 | ||||
Intravenous infusion | 2 | ||||
Multiple dosage regimens. | 2 | ||||
Non-linear pharmacokinetics. | 2 | ||||
Dosage adjustment in renal diseases. | 2 | ||||
Introduction: The scope and concerns of public health, health care system in Iraq | 1 | ||||
Measuring, Monitoring, and Evaluating the Health of a Population | 1 | ||||
Population screening and public health | 1 | ||||
Prevention and control of non-communicable diseases | 1 | ||||
Principles of infectious disease control | 1 | ||||
National immunization plan of Iraq. | 1 | ||||
Communicable diseases (infections through the gastro-intestinal tract, Infections through skin and mucous membranes, Infections through the respiratory tract) | 1 | ||||
Prevention and control of public health hazards ( Tobacco, alcohol, Public health aspects of illicit psychoactive drug use) | 1 | ||||
Major health problems (Obesity, Physical activity and health, Public mental health and suicide, Dental public health, Sexually transmitted infections, Chronic hepatitis and other liver disease, Tuberculosis …) | 2 | ||||
Nutritional disorders | 1 | ||||
Family health | 1 | ||||
Environmental health | 1 | ||||
Occupational health | 1 | ||||
Public Health | Travel health | 1 | |||
Introduction: a historic background of pharmacy practice. | 1 | ||||
Pharmacy Practice and the health care system | 2 | ||||
Health promotion in community pharmacy | 1 | ||||
Introduction to Pharmaceutical care | 1 | ||||
Pharmaceutical care planning | 2 | ||||
Community pharmacy management | 1 | ||||
Hospital pharmacy service. | 1 | ||||
Biosafety in pharmacy practice | 2 | ||||
Formulary management and Regulatory affairs | 2 | ||||
Rational Use of Drugs | 2 | ||||
Principles and Elements of Interpersonal Communication | 2 | ||||
Communication Skills | |||||
Nonverbal type of communication. | 2 | ||||
Barriers to communication. | 2 | ||||
Listening and empathic responding during communication. | 2 | ||||
Assertiveness. | 2 | ||||
Interviewing and assessment. | 2 | ||||
Helping patients to manage therapeutic regimens. | 2 | ||||
Patient counseling; counseling check list; point-by-point | |||||
discussion; | |||||
counseling scenario. | 2 | ||||
Medication safety and communication skills. | 2 | ||||
Strategies to meet specific needs. | 2 | ||||
Communicating with children and elderly about | |||||
medications. | 2 | ||||
Communication skills and inter-professional collaboration. | 2 | ||||
Electronic communication in healthcare. | 2 | ||||
Ethical behavior when communicating with patients. | 2 | ||||
Travel health | 1 | ||||
Health insurance | 1 | ||||
Hormones of the pituitary and thyroid glands. | 3 | ||||
Insulin and oral hypoglycemic drugs. | 4 | ||||
Adreno-corticosteroids. | 3 | ||||
The gonadal hormones and inhibitors. | 3 | ||||
Autacoids and autacoid antagonists | 3 | ||||
Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti- | 3 | ||||
inflammatory agents. | |||||
Drugs used in erectile dysfunction. | 2 | ||||
Drugs used in osteoporosis. | 2 | ||||
Pharmacology III | Drugs used in the management of obesity. | 2 | |||
Cancer Chemotherapy: Anticancer drugs and | 5 | ||||
immunosuppressants. | |||||
Organic Pharmaceutical | β-Lactam antibiotics (Penicillins); β-Lactamase inhibitors; | 9 | |||
Chemistry III | Cephalosporins and Monobactams. | ||||
Aminoglycosides and Chloramphenicol; Tetracylines; Macrolides; | 9 | ||||
Lincomycins and Polypeptides; Antiviral agents (properties of viruses, viral classification, products). | |||||
Sulfonamides (chemistry, nomenclature, mechanism of action, | 4 | ||||
resistance, toxicity, side effects, metabolism, protein binding, distribution and SAR); products; Sulfones. | |||||
Anti-neoplastic agents: Alkylating agents; Antimetabolites; | 17 | ||||
Antibiotics; Plant products; Miscellaneous compounds. | |||||
Hormones and related compounds; Future anti-neoplastic agents; | 6 | ||||
Monoclonal antibodies; Gene therapy of cancer. | |||||
Introduction to the concept of clinical pharmacy- its activities and professional responsibilities.( including current state of clinical pharmacy in Iraq) . | 1 | ||||
Clinical Pharmacy II | overview of pharmaceutical care practice (the patient care | ||||
process). | 1 | ||||
Hematologic disorders: Anemia and sickle cell disease. | 2 | ||||
Hypertension. | 2 | ||||
Ischemic heart diseases | 2 | ||||
Heart failure. | 2 | ||||
Peripheral vascular diseases. | 1 | ||||
– Asthma. | 2 | ||||
Chronic obstructive pulmonary disease ( COPD ). | 1 | ||||
Diabetes mellitus & Diabetic ketoacidosis (DKA) . | 2 | ||||
Peptic ulcer disease. | 2 | ||||
Tuberculosis | 1 | ||||
Infective meningitis | 1 | ||||
Respiratory tract infections | 2 | ||||
GIT infections | 1 | ||||
Gout and hyperuricemia | 1 | ||||
Rheumatoid arthritis (RA) and osteoarthritis (OA) | 2 | ||||
Osteoporosis and other metabolic bone disease. | 1 | ||||
Infectious Endocarditis | 1 | ||||
Surgical antibiotic prophylaxis | 1 | ||||
Urinary tract infection (UTI) | 1 | ||||
Introduction: general consideration; host factor, environmental | 3 | ||||
factors | |||||
of toxic effects. | |||||
Carcinogenesis. | 3 | ||||
Mutagenesis: | 1 | ||||
Target organs and systemic toxicology; Respiratory system, Liver, | 16 | ||||
Kidney, Skin, Nervous system, cardiovascular system, Blood. | |||||
General Toxicology | Toxic substances: Food additive and contaminants, Pesticides, | 15 | |||
Metals, | |||||
Radiation and radio active materials, plants, Solvents, | |||||
Environmental toxicology: Air pollution, water and soil pollutants, | 7 | ||||
Gases (Tear gas, Pepper spray), CO, Cyanide(H2S). | |||||
Principles of pharmaceutical processing; mixing; fluid mixing; | 7 | ||||
flow | |||||
characteristics; mechanisms of mixing; mixing equipments; batch and continuous mixing; mixer selection; solid mixing theory and particulate solid variables; forces and mechanisms. | |||||
Industrial Pharmacy I | |||||
Milling; pharmaceutical application; size measurement methods; | 7 | ||||
theory | |||||
and energy of commenution; types of mills; factors influencing milling; | |||||
selection of mill techniques; specialized drying methods. | |||||
Drying: definition; purpose; humidity measurement; theory of | 7 | ||||
drying; | |||||
drying of solids, and classification of dryer; specialized drying methods. | |||||
Clarification and filtration: Theory; filter media; filter aids; | 7 | ||||
selection of | |||||
drying method; non-sterile and sterile operations; integrity testing; equipments and systems (commercial and laboratory). | |||||
Sterilization; validation of methods; microbial death kinetics; | 7 | ||||
methods | |||||
of sterilization (thermal and non-thermal); mechanisms; evaluation. | |||||
Pharmaceutical dosage form design; pre-formulation; preliminary | 3 | ||||
evaluation; bulk characterization; solubility and stability analysis. | |||||
Pharmaceutical dosage forms; sterile products; development; | 7 | ||||
formulation; production; processing; quality control. | |||||
Fifth stage | |||||
Lecture title | |||||
hours | |||||
Basic concept of prodrugs; Covalent bonds (cleavable); Prodrugs of | 6 | ||||
functional groups; Types of prodrugs. | |||||
Chemical delivery systems; Polymeric prodrugs; Types and structure | |||||
of polymers; Cross-linking reagents. | |||||
Organic Pharmaceutical Chemistry IV | Drug targeting. | ||||
4 | |||||
Project. | |||||
4 | |||||
Combinatorial chemistry; Peptides and other linear structures; Drug | |||||
like molecules; Support and linker; Solution-phase combinatorial chemistry. | |||||
5 | |||||
Detection, purification and analgesics; Encoding combinatorial | |||||
libraries; | |||||
High-throughput screening; Virtual screening; Chemical diversity and library design. | 5 | ||||
Pharmaceutical dosage forms: Tablets; role in therapy; advantages | |||||
and | |||||
disadvantages; formulation; properties; evaluation; machines used in tableting; quality control; problems; granulation, and methods of production; excipients, and types of tablets. | |||||
10 | |||||
Tablet coating; principles; properties; equipments; processing; types | |||||
of | |||||
coating (sugar and film); quality control, and problems. | 4 | ||||
Capsules: Hard gelatin capsules; materials; production; filling | |||||
equipments; formulation; special techniques. | |||||
3 | |||||
Soft gelatin capsules: Manufacturing methods; nature of capsule shell | |||||
and content; processing and control; stability. | 2 | ||||
Micro-encapsulation; core and coating materials; stability; | |||||
Industrial Pharmacy II | equipments | ||||
and methodology. | 2 | ||||
Modified (sustained release) dosage forms; theory and concepts; | |||||
evaluation and testing; formulation. | |||||
3 | |||||
Liquids: Formulation; stability and equipments. | 3 | ||||
Suspensions: Theory; formulation and evaluation. | |||||
3 | |||||
Emulsions: Theory and application; types; formulation; equipments | |||||
and | |||||
quality control. | 3 | ||||
Semisolids: Percutaneouse absorption; formulation; types of bases | |||||
(vehicles) preservation; processing and evaluation. | |||||
3 | |||||
Suppositories: Rectal absorption; uses of suppositories; types of | |||||
bases; | |||||
manufacturing processes; problems and evaluation. | 3 | ||||
Pharmaceutical aerosols: Propellants; containers; formulation; types | |||||
and | |||||
selection of components; stability; manufacturing; quality control and testing. | 6 | ||||
Interpretation of Lab. data. | 2 | ||||
Acute coronary syndrome. | 2 | ||||
Therapeutic I | Arrhythmias | 2 | |||
Thrombosis | 2 | ||||
Dyslipidemia | 1 | ||||
Stroke | 2 | ||||
Shock | 2 | ||||
Liver cirrhosis | 2 | ||||
Viral hepatitis | 1 | ||||
Inflammatory bowel diseases | 2 | ||||
Acute renal failure (ARF) | 1 | ||||
Chronic renal failure (CRF) | 2 | ||||
Hemodialysis and peritoneal dialysis | 1 | ||||
Systemic lupus erythematosis (SLE) | 1 | ||||
Benign prostatic hyperplasia (BPH) | 1 | ||||
Acid – base disorders | 2 | ||||
Disorders of fluid and electrolytes | 2 | ||||
Urinary incontinence and pediatric enuresis | 1 | ||||
Epilepsy and status epilepticus | 2 | ||||
multiple sclerosis | 1 | ||||
Parkinson’s disease | 2 | ||||
Pain management | 2 | ||||
Headache disorders | 1 | ||||
glucoma | 2 | ||||
Parenteral nutrition | 2 | ||||
Enteral nutrition | 2 | ||||
Pharmacovigilance | 2 | ||||
Disorders of Carbohydrates metabolism, Hyperglycemia & Diabetes | |||||
mellitus, Hypoglycemia. | |||||
3 | |||||
Disorders of lipid metabolism. | |||||
2 | |||||
Liver Function Tests. | |||||
4 | |||||
Clinical Chemistry | Kidney Function Tests. | ||||
4 | |||||
Diagnostic enzymology. | |||||
4 | |||||
Hypothalamus & pituitary endocrinology, disorders of anterior | |||||
pituitary hormones, disorders of adrenal gland, hypopituitrism. | |||||
8 | |||||
Reproductive system, disorders of gonadal function in males & | |||||
females, biochemical assessment during pregnancy. | |||||
5 | |||||
Tumor markers. | |||||
4 | |||||
Drug interaction with laboratory Tests. | |||||
2 | |||||
Disorders of calcium metabolism | |||||
3 | |||||
Acid- Base Disorders. | |||||
4 | |||||
Initial Evaluation and Management of the Poisoned Patient. | 3 | ||||
Including pediatric poisoning and special consideration in the geriatric patient | |||||
Drug Toxicity: Over the counter drugs; caffeine; theophylline; | 3 | ||||
antihistamine and decongestant; non-steroidal anti-inflammatory drugs; vitamins. | |||||
Prescription Medications: Cardiovascular drugs; beta blockers; ACE | 13 | ||||
inhibitors; Digoxin; Calcium channel blocker; Antiarrhythmic agents; hypoglycemic drugs; Opiods; CNS depressants; tricyclic antidepressants; anti-cholinergic phenothiazines; CNS stimulant. | |||||
Clinical Toxicology | Drug of Abuse: Opioids; Cocaine; phencyclidine; marijuana; Lysergic acid. | 4 | |||
Chemical and Environmental Toxins: Hydrocarbones; Household | 3 | ||||
toxins; Antiseptic; Disinfectants; Camphor; moth repellents. | |||||
Botanicals and plants-derived toxins: Herbal preparation; Toxic | 4 | ||||
plants; | |||||
Poisonous mushrooms. | |||||
Project. | ( 1 | ||||
عورفلا عيمج | hours ) | ||||
, | |||||
Pharmacoeconomy | Course overview & basic principle of pharmacoeconomics | 2 | |||
Cost analysis | 6 | ||||
Cost effectiveness analyses (CEA). | 2 | ||||
1st mid-term examination. | 2 | ||||
Cost utility analyses (CUA). | 2 | ||||
Cost-benefit analysis (CBA) | 2 | ||||
Critical assessment of economic evaluation | 4 | ||||
2nd mid-term examination. | 2 | ||||
Drug-focused versus disease-focused frame work for | |||||
conducting | |||||
pharmacoeconomic analyses. | 2 | ||||
Introduction to epidemiology. | 2 | ||||
Project presentation. | 2 | ||||
Project presentation. | 2 | ||||
Therapeutic Drug Monitoring | Review of basic pharmacokinetic (PK) and pharmacodynamic | ||||
(PD) | 2 | ||||
Clinical PK equations and calculations | 3 | ||||
Clinical PK in special population and cases | 3 | ||||
Clinical PK/PD for Aminoglycosides | 2 | ||||
Clinical PK/PD for Vancomycin | 2 | ||||
Clinical PK/PD for Digoxin | 2 | ||||
Clinical PK/PD for Phenytoin | 3 | ||||
Clinical PK/PD for other Anticonvulsants (e.g., Carbamazepine, Valproic Acid, Phenobarbitone/Primidone, Ethosuxsimide | |||||
3 | |||||
Clinical PK/PD for Theophylline | 2 | ||||
Clinical PK/PD for Immunossprasants (e.g., Cyclosporine, | |||||
Tacrolimus | 2 | ||||
Clinical PK/PD for other Cardiovascular agents (e.g., Lidocaine, Procainamide/N-Acetyl Procainamide | |||||
2 | |||||
Clinical PK/PD of other drugs (e.g., Lithium), Anticancer agents, and Anticoagulats | |||||
4 | |||||
Clinical Pharmacy Practice in Internal Medicine: Clinical observation of | |||||
10 | |||||
cases; evaluation of the case sheets; case presentation; discussion and | |||||
evaluation. | |||||
Clinical Pharmacy Practice in Surgery wards: Clinical observation of | |||||
cases; evaluation of the case sheets; case presentation; discussion and | 5 | ||||
Hospital Training | evaluation. | ||||
Clinical Pharmacy Practice in Gynecology and Obstetrics Ward: | |||||
Clinical observation of cases; evaluation of the case sheets; case presentation; discussion and evaluation. | 5 | ||||
Clinical Pharmacy Practice in Pediatric Ward: Neurology , Cardiology , GIT , Birth defects , Sepesis , Meningitis | |||||
10 | |||||
Thyroid and parathyroid disorders | 2 | ||||
Contraception | 1 | ||||
Endometriosis | 1 | ||||
Menstruation related disorders | 1 | ||||
Therapeutic II | Hormonal replacement therapy (HRT) | 2 | |||
Cancer treatment and chemotherapy | 2 | ||||
Leukemias | 2 | ||||
Lymphomas and Multiple myeloma | 2 | ||||
Breast and prostate cancers | 2 | ||||
Adverse effects of chemotherapy | 1 | ||||
Human immunodeficiency viruse | 2 | ||||
Adrenal gland disorders | 1 | ||||
Pituitary gland disorders | 1 | ||||
Alzheimer’s disease | 1 | ||||
Schizophrenia | 2 | ||||
Depressive disorders | 2 | ||||
Anxiety disorders | 1 | ||||
Sleep disorders | 1 | ||||
Bipolar disorders | 2 | ||||
colorectal cancer | 1 | ||||
Diagnostic test basics, collecting &transporting specimens, | 4 | ||||
venipuncture, urine specimen, stool specimen. | |||||
Biochemical tests: Fasting blood glucose, Post-prandial glucose, Oral | 4 | ||||
glucose tolerance test. | |||||
Blood urea, Blood creatinine, Creatinine clearance, Uric acid. | 4 | ||||
Cholesterol, Lipoproteins, triglycerides. | 4 | ||||
Blood proteins, Bilirubin. | 4 | ||||
Calcium, Inorganic phosphate, Serum chloride | 4 | ||||
Alkaline phosphatase, Acid phosphatase, Alanine amiotransferase, | 4 | ||||
Aspartate aminotransferase, Lactate dehydrogenase, Creatine phosphokinase. | |||||
Serological tests: VDRL, ASO- Titer, Hepatitis tests. | 4 | ||||
Clinical Laboratory Training | C-reactive protein test, Rheumatic factor test, Rosebengal test, | 4 | |||
Typhoid | |||||
fever test( Widal test), Pregnancy Test. | |||||
General urine examination, urine specimen collection. | 4 | ||||
Hematological tests: RBC count, Hb, PCV, RBC indices, WBC | 4 | ||||
count, | |||||
Platelets count. | |||||
Blood typing, Coombs test, Bleeding time, ESR. | 4 | ||||
Microbiological tests: culture and sensitivity tests, Staining methods | 4 | ||||
Culture media, Enriched culture media for general use | 4 | ||||
Tests for identification of bacteria, Disk diffusion tests of sensitivity | 4 | ||||
to | |||||
antibiotics, Choice of drugs for disk test, bacterial disease and their laboratory diagnosis. | |||||
Biotechnology – introduction | 1 | ||||
Formulation of biotechnology product (biopharmaceutical | 4 | ||||
consideration) Microbial consideration- sterility-pyrogen viral decontamination Excipients of parentral products – solubility enhancer-anti adsorption agents buffer components-preservatives – osmotic agents | |||||
pharmaceutical biotechnology | Route of administration Parentral route Oral route Alternative | 5 | |||
routes ( nasal-pulmonary-rectal-buccal transdermal ) | |||||
Pharmacokinetic of peptides and proteins Introduction Elimination | 5 | ||||
of proteins (proteolysis-excretion-metabolism ) | |||||
Pharmaceutical consideration: The need for the dosage form. | 1 | ||||
General consideration for the dosage form. | 3 | ||||
Pre-formulation; physical description, microscopic examination. | 2 | ||||
Melting point; phase rule; particle size; polymorphism; solubility. | 2 | ||||
Permeability; pH; partition coefficient; pka; stability; kinetics; shelf | 2 | ||||
life. | |||||
Rate reaction; enhancing stability. | 2 | ||||
Formulation consideration: Excipients; definition and types; | 2 | ||||
appearance; palatability; flavoring. | |||||
Sweetening; coloring pharmaceuticals; preservatives; sterilization; | 2 | ||||
preservatives selection. | |||||
Dosage form Design | Biopharmaceutical considerations: Principle of drug absorption; | 4 | |||
dissolution of the drugs. | |||||
Bioavailability and bioequivalancy; FDA requirements. | 3 | ||||
Assessment of bioavailability; bioequivalence among drug products. | 3 | ||||
Pharmacokinetic principles: Half life; clearance; dosage regimen | 4 | ||||
considerations. | |||||
UV / visible spectroscopy; Sample handling and instrumentation; | 6 | ||||
Characteristic absorption of organic compounds; Rules for calculation of lambda max and application; Application of UV/visible; spectroscopy; Problems and solutions. | |||||
Advanced Pharmaceutical Analyses | |||||
Infra Red spectroscopy (theory and H-bonding effect; Sampling | 14 | ||||
techniques and interpretation of spectra; Characteristic group frequencies of organic compounds; Application of IR spectroscopy; Problems and solutions. | |||||
H1 –Nucleomagnetic Resonance (NMR) and C13-NMR spectroscopy; | 12 | ||||
Introduction, the nature of NMR absorption, chemical shifts and factors affecting them, information obtained from NMR spectra, more complex spin-spin splitting patterns, application of H1-NMR spectroscopy; | |||||
C13-NMR spectroscopy: introduction and characteristics, DEPT C13- NMR spectroscopy. | |||||
Mass spectroscopy: Introduction and interpreting Mass spectra; | 11 | ||||
interpreting Mass spectra fragmentation patterns, Mass behavior of some common functional groups. | |||||
elemental microanalysis CHNSO | 2 | ||||